MEDTIDE(03880),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community - To The Moon

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

03880 MEDTIDE

Not Yet Opened 12-22 16:08:08

30.000

+0.320

+1.08%

High30.260	Low29.400	Vol163.30K
Open29.580	D1 Closing29.680	Amplitude2.90%
Mkt Cap4.26B	Tradable Cap2.21B	Total Shares142.00M
T/O4.88M	T/O Rate0.22%	Tradable Shares73.60M
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

Disclaimer: HKEx Information Services Limited, its holding companies and/or any subsidiaries of such holding companies endeavour to ensure the accuracy and reliability of the information provided, but do not guarantee its absolute accuracy and reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.

{"stockData":{"symbol":"03880","market":"HK","secType":"STK","nameCN":"MEDTIDE","latestPrice":30,"timestamp":1766390888725,"preClose":29.68,"halted":0,"volume":163300,"delay":0,"floatShares":73598888,"shares":142000000,"eps":0.473384,"marketStatus":"Not Yet Opened","change":0.32,"latestTime":"12-22 16:08:08","open":29.58,"high":30.26,"low":29.4,"amount":4883898,"amplitude":0.028976,"askPrice":30,"askSize":1900,"bidPrice":29.8,"bidSize":900,"shortable":0,"etf":0,"ttmEps":0.88484,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1766453400000},"marketStatusCode":0,"adr":0,"listingDate":1751212800000,"exchange":"SEHK","adjPreClose":29.68,"openAndCloseTimeList":[[1766367000000,1766376000000],[1766379600000,1766390400000]],"volumeRatio":1.1080200831588913,"lotSize":100,"spreadScale":0,"tradeCurrency":"HKD"},"requestUrl":"/m/hq/s/03880","defaultTab":"news","newsList":[{"id":"1136210832","title":"Medtide Inc. (03880) Announces Monthly Return on Movements in Securities for November 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=1136210832","media":"Bulletin Express","labels":["SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1136210832?lang=en_us&edition=fundamental","pubTime":"2025-12-03 17:06","pubTimestamp":1764752802,"startTime":"0","endTime":"0","summary":"Medtide Inc. (stock code: 03880) issued a monthly return on movements in securities for the month ended 30 November 2025. The total issued share capital remains at RMB 141,800,000, comprising...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["03880"],"gpt_icon":0},{"id":"2585780961","title":"Medtide Inc.'s (HKG:3880) last week's 9.3% decline must have disappointed retail investors who have a significant stake","url":"https://stock-news.laohu8.com/highlight/detail?id=2585780961","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2585780961?lang=en_us&edition=fundamental","pubTime":"2025-11-22 06:42","pubTimestamp":1763764950,"startTime":"0","endTime":"0","summary":"Key Insights The considerable ownership by retail investors in Medtide indicates that they collectively have a greater...","market":"sg","thumbnail":"https://images.simplywall.st/asset/industry/9551728-choice1-main-header/1585186657000","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/9551728-choice1-main-header/1585186657000"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-3880/medtide-shares/news/medtide-incs-hkg3880-last-weeks-93-decline-must-have-disappo","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-3880/medtide-shares/news/medtide-incs-hkg3880-last-weeks-93-decline-must-have-disappo","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["03880","BK1141"],"gpt_icon":0},{"id":"1167576721","title":"Hong Kong Stocks Hit 52-Week Highs and Lows on November 21","url":"https://stock-news.laohu8.com/highlight/detail?id=1167576721","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1167576721?lang=en_us&edition=fundamental","pubTime":"2025-11-21 16:44","pubTimestamp":1763714683,"startTime":"0","endTime":"0","summary":"As of the market close on November 21, 14 stocks reached 52-week highs. Among them, KELFRED (01134), CHAOWEI HOLDINGS (08059), and CASSAVA RES (00841) led with surge rates of 42.11%, 30.56%, and...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01134","02011","02567","LU1166156734.SGD","08159","BK1109","BK1154","BK1122","BK1215","08549","01029","BK1126","BK1233","02367","LU2488822045.USD","BK1116","08487","02535","BK1531","01119","01304","BK1593","BK1147","00341","02579","06687","BK1520","BK1117","08178","01865","02508","BK1137","BK1516","BK1511","SG9999004311.SGD","BK1155","BK1163","03313","BK1213","BK1601","BK1191","08059","03880","BK1547","BK1239","BK1500","BK1606","02562","03882","BK1140","BK1214","00180","02587","BK1247","01004","BK1588","00182","00841","BK1229","00638","01855","BK1104","BK1209","02431","BK1144","09688","BK1151","09860","01830","BK1141","08319","BK1148","BK1161","08613","BK1222","06887","BK1542","03398","06677","BK1578","BK1149","02651","BK1591","BK1253","BK1596","00325","02453","02188","06068","BK1533","BK1558","LU0173614495.USD","00314","02818","01121","08500","00610","BK1186","00397","BK1237","BK1205","00599","02543","06960","BK1258","BK1577","BK1556","02515","BK1228","LU0287142896.SGD","00040","03669","00848","01498","BK1101","00500","02246","BK1170","BK1135","08606","06603","06989","BK1183","08019","BK1096","BK1585","BK1227","BK1574","01653","BK1225","BK1124","BK1589","BK1167","BK1219","BK1168","LU0211977185.USD","00917","01773","BK1554","BK1249","01745","03348","BK1594","08223","01274","00699","BK1188","02591","BK1207","03406","09878","01268"],"gpt_icon":1},{"id":"1196108913","title":"Medtide Inc. (03880) Releases Monthly Return as of 31 October 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=1196108913","media":"Bulletin Express","labels":["dataReport","SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1196108913?lang=en_us&edition=fundamental","pubTime":"2025-11-05 17:23","pubTimestamp":1762334626,"startTime":"0","endTime":"0","summary":"Medtide Inc. (03880) submitted its monthly return for the period ended 31 October 2025 on 05 November 2025. The announcement indicates that the total issued share capital of the company remained...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["03880"],"gpt_icon":0},{"id":"1138867778","title":"MEDTIDE (03880): Wu Dongcheng Appointed as Joint Company Secretary","url":"https://stock-news.laohu8.com/highlight/detail?id=1138867778","media":"Stock News","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1138867778?lang=en_us&edition=fundamental","pubTime":"2025-09-26 16:56","pubTimestamp":1758876993,"startTime":"0","endTime":"0","summary":"MEDTIDE (03880) announces that Mr. Li Zhongcheng has tendered his resignation as (i) joint company secretary; (ii) authorized representative under Rule 3.05 of the Rules Governing the Listing of...","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1141","03880"],"gpt_icon":0},{"id":"2570064299","title":"Medtide Inc. Reports 28.5% Rise in Revenue and 101.7% Increase in Net Profit for H1 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2570064299","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2570064299?lang=en_us&edition=fundamental","pubTime":"2025-09-25 16:33","pubTimestamp":1758789184,"startTime":"0","endTime":"0","summary":"Medtide Inc. reported its interim results for the first half of 2025, with revenue rising to RMB 253.8 million from RMB 197.5 million in the same period a year earlier, representing a 28.5% increase. Gross profit reached RMB 155.0 million, up from RMB 107.4 million, with the gross profit margin increasing to 61.1% from 54.4%. Profit before tax was RMB 115.7 million, compared to RMB 58.5 million in the prior-year period. Net profit for the period rose to RMB 102.0 million from RMB 50.6 million, resulting in a net profit margin of 40.2%, up from 25.6%. The company also reported an adjusted net profit  of RMB 104.1 million, compared to RMB 90.6 million in the previous period. During the period, Medtide Inc. completed its global offering and became a listed company in June 2025. The company stated that it funded its cash requirements primarily through business operations, capital contributions from shareholders, and the issuance of equity shares. Medtide Inc. remains focused on driving sus","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250925:nNDL6Sytsm:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["03880","BK1141"],"gpt_icon":0},{"id":"2563100520","title":"Medtide Inc. Reports 28.5% Increase in Revenue and 101.7% Surge in Net Profit for H1 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2563100520","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2563100520?lang=en_us&edition=fundamental","pubTime":"2025-08-29 17:08","pubTimestamp":1756458509,"startTime":"0","endTime":"0","summary":"Medtide Inc. has reported unaudited consolidated results for the six months ended June 30, 2025. The company's revenue increased by 28.5% year-on-year, reaching RMB 253.8 million, driven by its CRDMO services. Gross profit grew significantly by 44.3%, amounting to RMB 155.0 million, with the gross profit margin rising to 61.1% from 54.4% in the previous year. Profit before tax saw a notable increase of 97.7% to RMB 115.7 million, and profit for the period surged by 101.7% to RMB 102.0 million, resulting in a net profit margin of 40.2%. Geographically, revenue from the United States showed a strong performance, increasing to RMB 147.7 million from RMB 122.0 million. In contrast, revenue from Mainland China decreased to RMB 38.9 million from RMB 56.6 million. Revenue from Japan rose to RMB 10.5 million, up from RMB 2.6 million in the same period last year. The results highlight significant customer contributions, with Customer A accounting for RMB 99.4 million and Customer B contributing","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250829:nNDL2pC2rB:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["03880"],"gpt_icon":0},{"id":"2563010069","title":"Medtide Inc -Intend to Either Construct or Acquire New Production Facilities in Coming Years","url":"https://stock-news.laohu8.com/highlight/detail?id=2563010069","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2563010069?lang=en_us&edition=fundamental","pubTime":"2025-08-29 17:08","pubTimestamp":1756458485,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250829:nFWN3UK21V:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK1141","03880"],"gpt_icon":0},{"id":"2563010062","title":"Medtide Inc -  Hy Profit RMB102 Mln","url":"https://stock-news.laohu8.com/highlight/detail?id=2563010062","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2563010062?lang=en_us&edition=fundamental","pubTime":"2025-08-29 17:08","pubTimestamp":1756458485,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250829:nFWN3UK21V:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK1141","03880"],"gpt_icon":0},{"id":"1182606058","title":"Hong Kong Stock Alert | MEDTIDE (03880) Surges Over 9% to Record High as Interim Results Approach, Company Ranks as World's Third-Largest Peptide CRDMO","url":"https://stock-news.laohu8.com/highlight/detail?id=1182606058","media":"Stock News","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1182606058?lang=en_us&edition=fundamental","pubTime":"2025-08-21 11:12","pubTimestamp":1755745941,"startTime":"0","endTime":"0","summary":"MEDTIDE (03880) surged over 9% in morning trading, reaching a high of HK$40.54 and setting a new record since its listing. As of press time, the stock was up 8.9% to HK$40.14, with turnover of...","market":"other","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1141","03880"],"gpt_icon":0},{"id":"2554748842","title":"Medtide Inc. Announces Acceptance of H Share Full Circulation Plan Application by China Securities Regulatory Commission","url":"https://stock-news.laohu8.com/highlight/detail?id=2554748842","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2554748842?lang=en_us&edition=fundamental","pubTime":"2025-07-27 18:25","pubTimestamp":1753611935,"startTime":"0","endTime":"0","summary":"Medtide Inc., a joint stock company incorporated in the People's Republic of China, has announced that the China Securities Regulatory Commission  has accepted its application for the H Share Full Circulation Plan. This regulatory acceptance pertains to the conversion of 68,201,112 unlisted shares into H shares, each with a par value of RMB1.0. This development is a significant step towards the proposed implementation of the full circulation of H shares for certain shareholders of the company. The conversion and listing process will still require adherence to additional procedures mandated by the CSRC, the Hong Kong Stock Exchange, and other relevant regulatory authorities. Medtide Inc. has advised shareholders and potential investors to exercise caution when dealing in the company's securities. Further announcements will be made as details of the conversion and listing are finalized.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligenc","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250727:nNDLb80D2T:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["03880"],"gpt_icon":0},{"id":"1181216476","title":"Stock Track | Medtide Soars 5.23% Intraday as Investor Enthusiasm Builds Following Hong Kong IPO","url":"https://stock-news.laohu8.com/highlight/detail?id=1181216476","media":"Stock Track","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1181216476?lang=en_us&edition=fundamental","pubTime":"2025-06-30 13:06","pubTimestamp":1751260007,"startTime":"0","endTime":"0","summary":"Medtide Inc. , a peptide-focused CRDMO, is experiencing a significant surge in its stock price during intraday trading on Monday. The company's shares are soaring 5.23%, marking a strong reversal from its initial performance at the market open.This impressive rally comes on the heels of Medtide's recent initial public offering  in Hong Kong. The company successfully raised HK$428.8 million in net proceeds after pricing its shares at HK$30.60, the top end of the indicative price range. The IPO ga","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"6236850a5ccd706a69e00421affe9b09","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"Stock Track | Medtide Soars 5.23% Intraday as Investor Enthusiasm Builds Following Hong Kong IPO","news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_en","symbols":["03880"],"gpt_icon":1},{"id":"2547033547","title":"Medtide Nets HK$429 Million from Hong Kong IPO, Prices Shares at Upper Limit of Guidance","url":"https://stock-news.laohu8.com/highlight/detail?id=2547033547","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2547033547?lang=en_us&edition=fundamental","pubTime":"2025-06-30 07:19","pubTimestamp":1751239152,"startTime":"0","endTime":"0","summary":"Medtide Inc. (HKG:3880) took in HK$428.8 million in net proceeds from its initial public offering in Hong Kong after pricing the shares at the top end of the indicative price range.The peptide-focused","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["03880"],"gpt_icon":1},{"id":"2546476744","title":"BRIEF-Medtide Announces Final Offer Price Under Global Offering HK$30.60 Per H Share","url":"https://stock-news.laohu8.com/highlight/detail?id=2546476744","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2546476744?lang=en_us&edition=fundamental","pubTime":"2025-06-27 22:25","pubTimestamp":1751034302,"startTime":"0","endTime":"0","summary":"BRIEF-Medtide Announces Final Offer Price Under Global Offering HK$30.60 Per H ShareJune 27 (Reuters) - Medtide Inc 3880.HK:FINAL OFFER PRICE UNDER GLOBAL OFFERING HK$30.60 PER H SHAREFurther company coverage: 3880.HK ((Reuters.Briefs@thomsonreuters.com;))","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250627:nFWN3SU0GP:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["03880"],"gpt_icon":0},{"id":"1135832183","title":"Pharmaceutical Services Firm Medtide Rises 2% in Hong Kong Grey Market Trading","url":"https://stock-news.laohu8.com/highlight/detail?id=1135832183","media":"Tiger Newspress","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1135832183?lang=en_us&edition=fundamental","pubTime":"2025-06-27 16:20","pubTimestamp":1751012421,"startTime":"0","endTime":"0","summary":"Pharmaceutical services firm $Medtide(03880)$ rose 1% in Hong Kong grey market trading.Medtide was founded in 2020 but a key subsidiary, Zhongtai Biochemical,started operating in 2001 as a peptide-foc","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"6236850a5ccd706a69e00421affe9b09","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["03880"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.medtideinc.com","stockEarnings":[{"period":"1week","weight":0.0526},{"period":"1month","weight":0.0699},{"period":"3month","weight":-0.0196},{"period":"6month","weight":-0.0196},{"period":"ytd","weight":-0.0196}],"compareEarnings":[{"period":"1week","weight":0.0067},{"period":"1month","weight":0.0231},{"period":"3month","weight":-0.0137},{"period":"6month","weight":0.0542},{"period":"1year","weight":0.3084},{"period":"ytd","weight":0.2862}],"compareStock":{"symbol":"HSI","name":"HSI"},"description":"Medtide Inc is a China-based company mainly engaged in the contract research, development and manufacturing of peptide. The Company mainly provides contract research organization (CRO) services, namely peptide new chemical entity (NCE) discovery synthesis, contract development and manufacturing organization (CDMO) services, namely peptide chemistry, manufacturing, and control (CMC) development and commercial manufacturing. The Company's services primarily focus on providing customers with active pharmaceutical ingredients (APIs) rather than drug products. The Company also provides customers with peptide drug development, production, and CMC filing support services. The Company mainly operates its business in the domestic market and overseas markets.","exchange":"SEHK","name":"MEDTIDE","nameEN":"MEDTIDE"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.35.12","shortVersion":"4.35.12","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"MEDTIDE(03880),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest MEDTIDE(03880) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"MEDTIDE,03880,MEDTIDE股票,MEDTIDE股票老虎,MEDTIDE股票老虎国际,MEDTIDE行情,MEDTIDE股票行情,MEDTIDE股价,MEDTIDE股市,MEDTIDE股票价格,MEDTIDE股票交易,MEDTIDE股票购买,MEDTIDE股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"MEDTIDE(03880),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest MEDTIDE(03880) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}